Public health concerns regarding off-label use of GLP-1 receptor agonists

Commentary highlights the risks of using weight-loss medications like Ozempic without clinical necessity, emphasizing the potential for long-term health consequences. The analysis underscores a shift in focus from lifestyle-based health management to pharmaceutical reliance.